Central Nervous System
Practical Radiation Oncology
PRO 07 - PRO - Central Nervous System
9:45 AM - 11:00 AM
Location: Room 304
Session Type: Educational
1.25 AMA PRA Category 1 Credits™
1.25 CAMPEP Credits
1.50 MDCB Credits
This event is ticketed and requires separate registration and an additional fee. Space is limited, so please register early. Please note that events and fees are subject to change.
Recent advances in radiation therapy techniques and the success of new systemic therapies, such as targeted agents and immunotherapy, have improved outcomes for many patients with brain metastases. However there is now more confusion now on the role of Whole brain RT versus SRS and implications of targeted agents in managing these patients. There is also new information on gliomas, including the new WHO classification and this session will review the current state of knowledge on both high and low grade gliomas. The faculty will also discuss ongoing and proposed studies on this topic. Following the session, attendees should have a better grasp of the new information and clinical trials for this group of patients and to apply this knowledge when evaluating treatment options and making treatment decisions for their patients.
- Apply 2016 WHO classification (for gliomas) and prognostic factors (for both primary and secondary CNS tumors) for optimal evaluation and testing prior to treatment.
- Determine appropriate treatment paradigms using evidence-based management for patients with brain metastases and gliomas and create detailed treatment plans for individual patients based on particular information about the case.
9:45 AM - 10:05 AM
Updates In The Management of Brain Metastases
Speaker: – University of Washington
10:05 AM - 10:25 AM
Recent Advances In The Evaluation and Management Of Gliomas (both low grade and high grade)
Speaker: – Washington University, St. Louis